HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
- PMID: 9450538
- DOI: 10.1016/s0014-5793(97)01475-0
HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor
Abstract
We prepared a specific antagonist for hepatocyte growth factor (HGF) and designated it HGF/NK4. HGF/NK4 is composed of N-terminal 447 amino acids of the alpha-chain of HGF, thus contains the N-terminal hairpin domain and subsequent four kringle domains. HGF/NK4 competitively inhibited the specific binding of HGF to the receptor. Importantly, HGF/NK4 neither stimulated DNA synthesis of primary cultured rat hepatocytes (mitogenesis) nor induced cell scattering (motogenesis) and branching tubulogenesis (morphogenesis) of MDCK renal epithelial cells, however, HGF/NK4 almost completely inhibited the mitogenic, motogenic, and morphogenic activities of HGF. HGF/NK4 also suppressed tyrosine phosphorylation of the c-Met/HGF receptor induced by HGF. Apparently this is the first documentation of a specific antagonist which abrogates the mitogenic, motogenic, and morphogenic activities of HGF.
Similar articles
-
Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses.J Biol Chem. 1998 Sep 4;273(36):22913-20. doi: 10.1074/jbc.273.36.22913. J Biol Chem. 1998. PMID: 9722511
-
Kringle 1-4 of hepatocyte growth factor inhibits proliferation and migration of human microvascular endothelial cells.Biochem Biophys Res Commun. 2000 Dec 29;279(3):846-52. doi: 10.1006/bbrc.2000.4034. Biochem Biophys Res Commun. 2000. PMID: 11162438
-
HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.Cancer Res. 2000 Dec 1;60(23):6737-43. Cancer Res. 2000. PMID: 11118060
-
NK4 gene therapy targeting HGF-Met and angiogenesis.Front Biosci. 2008 Jan 1;13:1943-51. doi: 10.2741/2813. Front Biosci. 2008. PMID: 17981681 Review.
-
Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.Princess Takamatsu Symp. 1994;24:195-213. Princess Takamatsu Symp. 1994. PMID: 8983076 Review.
Cited by
-
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.Mol Cell Biol. 2000 Mar;20(6):2055-65. doi: 10.1128/MCB.20.6.2055-2065.2000. Mol Cell Biol. 2000. PMID: 10688652 Free PMC article.
-
Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.Pharm Res. 2004 Jul;21(7):1109-18. doi: 10.1023/b:pham.0000032996.95518.dc. Pharm Res. 2004. PMID: 15290849
-
Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.Cancer Sci. 2009 Jul;100(7):1351-8. doi: 10.1111/j.1349-7006.2009.01184.x. Epub 2009 May 12. Cancer Sci. 2009. PMID: 19438869 Free PMC article.
-
MET: a critical player in tumorigenesis and therapeutic target.Cold Spring Harb Perspect Biol. 2013 Jul 1;5(7):a009209. doi: 10.1101/cshperspect.a009209. Cold Spring Harb Perspect Biol. 2013. PMID: 23818496 Free PMC article. Review.
-
NK4, an HGF antagonist, prevents hematogenous pulmonary metastasis by inhibiting adhesion of CT26 cells to endothelial cells.Clin Exp Metastasis. 2009;26(5):447-56. doi: 10.1007/s10585-009-9244-0. Epub 2009 Feb 21. Clin Exp Metastasis. 2009. PMID: 19234748
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous